/Research Database
← Research Database
Sehr niedrig2026

Assessment of safety profile and anti-obesity effects of innovative plant-based food formulations in a zebrafish diet-induced obesity model.

Justyna Magdalena Hermanowicz, Sandra Budziak, Renata Markiewicz-Żukowska, Anna Puścion-Jakubik et al.

Kernaussage

The plant-based food formulations F1, F2, and F3 were found to be safe in zebrafish and significantly reduced body weight, glucose, total cholesterol, triglycerides, and visceral fat accumulation in a diet-induced obesity model.

Abstract

Obesity is a complex metabolic disorder associated with impaired glucose, lipid metabolism and excessive visceral fat accumulation. Therefore, the development of effective dietary strategies, including functional foods, has attracted increasing interest. This study aimed to evaluate the safety and the metabolic effects of three food formulations (F1, F2, and F3) using a zebrafish model. The safety profile of the complex of active substances was assessed in zebrafish embryos and larvae by evaluating survival, hatching rate, spontaneous movement, morphological abnormalities, and cardiac function. To investigate metabolic effects, diet-induced obesity was established in adult zebrafish. Supplementation with F1, F2, or F3 did not toxicity or developmental defects at early life stages. It resulted in significant reductions in body weight, glucose, triglycerides, and total cholesterol levels compared to obese controls. Additionally, formulations reduced visceral fat content, while F1 and F2 also significantly decreased subcutaneous fat. These findings demonstrate that the tested food formulations are safe and exert beneficial effects on metabolic parameters and fat accumulation in zebrafish. The results suggest their potential as functional dietary interventions contributing to the amelioration of diet-induced obesity-related metabolic dysfunction.

Kein medizinischer Rat. Die dargestellten Studien dienen der wissenschaftlichen Information und ersetzen keine ärztliche Beratung. Bei gesundheitlichen Fragen wende dich an eine approbierte Ärztin oder einen Arzt.

Quelle: PubMed Central / National Library of Medicine (NLM). Apollion steht in keiner Verbindung mit NLM und wird von NLM nicht empfohlen. Evidenzgrade bewerten die methodische Studienqualität — nicht die inhaltliche Richtigkeit.

Lizenz: CC BY — Inhalte werden ausschließlich aus Open-Access-Quellen mit kommerziell nutzbaren Lizenzen (CC0, CC BY, CC BY-SA) indexiert.